Korean J Hematol 1994; 29(2):
Published online June 30, 1994
© The Korean Society of Hematology
정철원, 안진석, 박선양, 김병국, 김노경
서울대학교 의과대학 내과학교실
Background : Anecdotal reports on the changes of tissue-type plasminogen activator(tPA), plasminogen activator inhibitor-1(PAI-1), von Willebrand factor(vWF) in
patients with disseminated intravascular coagulation(DIC) have not been constant. Development of DIC has been well documented in patients with hemorrhagic fever with
renal syndrome(HFRS), Tsutsugamushi disease, snake bite, acute promyelocytic leukemia. So we measured the levels of tPA, PAI-1 and vWF during different stages of DIC to elucidate the role of endothelial perturbation in the pathogenesis of those diseases.
Methods: Blood samples from 24 patients with DIC were collected daily during admission and once during convalescent period. tPA and PAI-1 were measured using
commercially available ELISA kits and vWF using rocket immunoelectrophoresis.
Results: tPA, PAI-1 and vWF in 9 serologically proven patients with HFRS had peaks during the 4-5th days of disease and decreased to normal since the 10th day of
disease. Ten Tsutsugamushi disease patients showed dual peaks during the first 14 days and the tPA peak preceded PAI-1 peak by 2-3 days. There had been only a slight
increase in tPA, PAI-1 and vWF in 2 patients with snake bite and 3 patients with acute promyelocytic leukemia.
Conclusion: In patients with HFRS and Tsutsugamushi disease plasma concentration of tPA, vWF and PAI-1 increased during developmental stage of DIC, and normalized
as DIC resolved.
Keywords DIC; Tissue-type plasminogen activator; Plasminogen activator inhibitor-1; von Willebrand factor;
Korean J Hematol 1994; 29(2): 199-206
Published online June 30, 1994
Copyright © The Korean Society of Hematology.
정철원, 안진석, 박선양, 김병국, 김노경
서울대학교 의과대학 내과학교실
Chul Won Jung, Jin Seok Ahn, Seonyang Park, Byoung Kook Kim, Noe Kyoung Kim
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
Background : Anecdotal reports on the changes of tissue-type plasminogen activator(tPA), plasminogen activator inhibitor-1(PAI-1), von Willebrand factor(vWF) in
patients with disseminated intravascular coagulation(DIC) have not been constant. Development of DIC has been well documented in patients with hemorrhagic fever with
renal syndrome(HFRS), Tsutsugamushi disease, snake bite, acute promyelocytic leukemia. So we measured the levels of tPA, PAI-1 and vWF during different stages of DIC to elucidate the role of endothelial perturbation in the pathogenesis of those diseases.
Methods: Blood samples from 24 patients with DIC were collected daily during admission and once during convalescent period. tPA and PAI-1 were measured using
commercially available ELISA kits and vWF using rocket immunoelectrophoresis.
Results: tPA, PAI-1 and vWF in 9 serologically proven patients with HFRS had peaks during the 4-5th days of disease and decreased to normal since the 10th day of
disease. Ten Tsutsugamushi disease patients showed dual peaks during the first 14 days and the tPA peak preceded PAI-1 peak by 2-3 days. There had been only a slight
increase in tPA, PAI-1 and vWF in 2 patients with snake bite and 3 patients with acute promyelocytic leukemia.
Conclusion: In patients with HFRS and Tsutsugamushi disease plasma concentration of tPA, vWF and PAI-1 increased during developmental stage of DIC, and normalized
as DIC resolved.
Keywords: DIC, Tissue-type plasminogen activator, Plasminogen activator inhibitor-1, von Willebrand factor,